Sudarshan Pharma Industries Share Price

    BSE
    30.7
    +0.92 (3.39%)
    SUDARSHAN • 04 Jul, 2025 | 03:25 PM
    BUY
    The current prices are delayed, login or Open Demat Account for live prices.

    Sudarshan Pharma Industries Stock Performance

    1W Return8.05
    1Y Return262.29
    Today's Low29.65
    Prev. Close29.78
    Mkt Cap (Cr.)723.66
    1M Return-3.00
    3Y Return0.00
    52-Week High53.5
    Open29.78
    PE Ratio40.09
    6M Return-38.15
    Today's High31.26
    52-Week Low8.19
    Face Value1

    Sudarshan Pharma Industries Company background

    Founded in: 2008
    Managing director: Hemal V Mehta
    Sudarshan Pharma Industries Limited was initially incorporated as a Private Limited Company with the name Sudarshan Specialty Chemsolve Private Limited on July 23, 2008 with the Registrar of Companies, Mumbai. Later in year 2016. name of the Company changed from Sudarshan Specialty Chemsolve Private Limited to Sudarshan Pharma Industries Private Limited on 17 December 2016. Thereafter, the Company converted into a Public Limited and name of the Company was changed to Sudarshan Pharma Industries Limited on January 5, 2017. The Company was promoted by Mr. Hemal V. Mehta Mr. Sachin V. Mehta, who have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry. At present, Company perates in pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. It exports primarily to South East Asia, Middle East, and North Africa. The Companys services include contract manufacturing and supplying generic pharmaceutical formulations to healthcare institutions through its distribution network.The Company outsources its manufacturing facility, deal in Import and Exports, indenting and Supply in Specialty chemicals, API its intermediate. As per the clients need and requirement, the company provides order and get them manufactured from various suppliers in India and abroad regularly. Specialty chemicals and Intermediates having wide application in pharma, paint, food and adhesive Industry. It is also involved in Contract Manufacturing, outsource Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals. It also offer services of QC and Formulation Development to provide customised solutions to our customers and assist them in sourcing the innovative products as per their needs. The Company carries about Ethical marketing of Pharmaceutical formulation products in the Domestic and International market through distribution network and Sales force under its own brand. Presently, the Company has joined hands with regular suppliers having FDA and WHO approved plant along with their own unit to supply pharma formulation and more than 100 generic pharma products. These units manufacture tablets, capsules, dry powder, dry injections powder, liquids, Injections dry injections for their own brands.Apart from these, the Company has launched wide products range in pharma formulation such as Setdown, Pulmo relief, Fix Pollen, Flupimac and has established goodwill for quality products and have regular clients for the same. Further, it supplies generic pharmaceutical formulation as Make to order for bulk supply to the hospital, Health Centre of Corporate, Municipality and exports.The Company operate both in domestic and international markets. Presently, it is supplying Active Pharmaceutical Ingredients(APIs), Intermediates Finished Dosage Formulations (FDFs) and Specialty Chemicals (SCs) in the domestic markets. It has entered into MOU / Agreements with Storage Houses / Warehouses facility providers at Bhiwandi Thane, Maharashtra, Wada Palghar, Maharashtra and Baddi, Himachal Pradesh for using their premises for the stock keeping of the products. The Company has also entered into Lease Agreement with Group Company, Sudarshan Chempharm LLP for using its premises and land to set up proposed Manufacturing and Storage / Warehouse Facility at Wada, in Maharashtra.In domestic pharmaceuticals markets, currently, the Company has good presence and is servicing through a Supply Chain Network of Consignee Agents with products range. It also provide onsite support assistance to clients using their Drug Intermediates and Specialty Chemicals.The Company launched the Initial Public Offer by issuing 68,62,400 Equity Shares having the face value of Rs 10 each by raising funds aggregating to Rs. 50 Crore, via fresh issue in March, 2023.Ratna Lifesciences Private Limited was incorporated as a wholly owned subsidiary company on November 10, 2023. Life Science Chemical Private Limited was incorporated on August 23, 2023.In FY 202425, Company achieved development of the molecule VITAMIN B6 (Pyridoxine Hydrochloride) from base root till the finished product and also manufactured all the intermediary products required to manufacture the finished API products of VITAMIN B6. It also achieved first milestone in developing the sample for the molecule VITAMIN B1 (Thiamine Hydrochloride) from Base Root for Manufacturing Process of VITAMIN B1.

    As of 04 Jul, 2025, Sudarshan Pharma Industries share price is ₹30.1. The stock opened at ₹29.8 and had closed at ₹29.8 the previous day. During today’s trading session, Sudarshan Pharma Industries share price moved between ₹29.65 and ₹31.26, with an average price for the day of ₹30.45. Over the last 52 weeks, the stock has recorded a low of ₹8.19 and a high of ₹53.50. In terms of performance, Sudarshan Pharma Industries share price has declined by 38.2% over the past six months and has increased by 258.80% over the last year.

    Read More
    View details of Market Depth

    Sudarshan Pharma Industries Fundamental

    Market Cap (in crs)

    723.66

    Face Value

    1

    Turnover (in lacs)

    68.56

    Key Metrics

    Qtr Change %
    43.79% Fall from 52W High
    -4.1
    Dividend yield 1yr %
    0

    Top Mutual Fund Invested in Sudarshan Pharma Industries

    Promoter
    57.4%
    Foreign Institutions
    18.4%
    Public
    24.2%
    Promoter
    57.4%
    Foreign Institutions
    13.1%
    Public
    29.5%
    Promoter
    57.4%
    Foreign Institutions
    1.4%
    Public
    41.2%

    Sudarshan Pharma Industries Technical Analysis

    Moving Averages Analysis
    30.7
    Current Price
    Bullish Moving Averages
    11
    Bearish Moving Averages
    5
    5Day EMA
    29.60
    10Day EMA
    29.40
    12Day EMA
    29.40
    20Day EMA
    29.40
    26Day EMA
    29.50
    50Day EMA
    30.00
    100Day EMA
    31.20
    200Day EMA
    30.30
    5Day SMA
    29.80
    10Day SMA
    28.80
    20Day SMA
    29.50
    30Day SMA
    30.00
    50Day SMA
    29.50
    100Day SMA
    30.60
    150Day SMA
    35.00
    200Day SMA
    35.90
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    228000 Rs
    228000 Rs
    Week Rs
    304000 Rs
    304000 Rs
    Month Rs
    268545 Rs
    268545 Rs
    30.33
    Pivot
    Resistance
    First Resistance
    31.00
    Second Resistance
    31.94
    Third Resistance
    32.61
    Support
    First Support
    29.39
    Second support
    28.72
    Third Support
    27.78
    Relative Strength Index
    53.30
    Money Flow Index
    67.29
    MACD
    -0.18
    MACD Signal
    -0.32
    Average True Range
    1.27
    Average Directional Index
    15.05
    Rate of Change (21)
    -4.54
    Rate of Change (125)
    -32.56
    Name
    Holding Percent
    Multitude Growth Funds Limited
    5.52
    Coeus Global Opportunities Fund
    3.68
    Century India Opportunity Fund PC
    2.39
    Radiant Global Fund - Class B Participating Shares
    2.13
    Eminence Global Fund PCC - Eubilia Capital Partners
    1.83
    Nexpact Limited
    1.34

    Sudarshan Pharma Industries Latest News

    02 JUL 2025 | Wednesday

    Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    01 JUL 2025 | Tuesday

    Sudarshan Pharma Industries Ltd - 543828 - Annual General Meeting On Friday, 25Th July 2025 At 3.00 P.M. IST

    01 JUL 2025 | Tuesday

    Sudarshan Pharma Industries Ltd - 543828 - Reg. 34 (1) Annual Report.

    View More

    Sudarshan Pharma Industries Share Price FAQs

    You can easily buy Sudarshan Pharma Industries shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Sudarshan Pharma Industries share price is ₹53.5 and ₹8.19 as of 4/7/2025.

    Please be aware that Sudarshan Pharma Industries stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.53
    +0.26 (+0.40%)
    139.24
    -0.46 (-0.33%)
    689.05
    -1.35 (-0.20%)
    2,599.10
    -12.10 (-0.46%)
    166.67
    -0.85 (-0.51%)
    391.40
    +0.75 (+0.19%)
    163.01
    -2.90 (-1.75%)
    261.40
    +0.55 (+0.21%)
    427.55
    +1.30 (+0.30%)
    401.00
    +1.10 (+0.28%)
    Top Gainers
    925.30
    +15.15 (+1.66%)
    1,640.70
    +22.00 (+1.36%)
    1,307.40
    +16.10 (+1.25%)
    1,442.80
    +16.90 (+1.19%)
    270.05
    +3.00 (+1.12%)
    Top Losers
    5,456.00
    -735.00 (-11.87%)
    163.01
    -2.90 (-1.75%)
    5,629.00
    -87.00 (-1.52%)
    1,655.20
    -16.70 (-1.00%)
    12,646.00
    -106.00 (-0.83%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -